LIGHT SCIENCES ONCOLOGY, INC.

APTOCINE

Pharmaceuticals used for treatment of neoplasms, inflammation, pain, and for treatment in the areas of immunology, oncology, ophthalmology, urology, dermatology, vascular systems, lymphatic systems, infectious diseases, and unwanted tissue reduction;

LIGHT INFUSION

pharmaceuticals, namely, energy-activated compounds used in conjunction with phototherapeutic devices for treatment in the areas of oncology, ophthalmology, cardiovascular systems, infectious diseases, urological diseases, and adipose tissue reduction;phototherapeutic devices for medical purposes;

LIGHT SCIENCES ONCOLOGY

phototherapeutic devices for medical purposes and pharmaceuticals, namely, energy-activated compounds, all sold as a unit and used for treatment in the areas of oncology, ophthalmology, cardiovascular systems, infectious diseases, urological diseases and adipose tissue reduction;LIGHT AND ONCOLOGY;

LITX

The mark consists of the first letter is upper case with the remaining three letters lower case. the first two letters are red followed by the last two letters being black and intertwined by letter three flowing into letter four.;The color(s) the logo maintains the following color scheme, L is red, i is red, t is black, and x is black. is/are claimed as a feature of the mark.;Medical device for treating cancer; Phototherapeutic apparatus for medical purposes;